About 100 reports

  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF IRRITABLE BOWEL SYNDROME TO GASTROINTESTINAL CLINICAL TRIALS
  • PROPORTION OF IRRITABLE BOWEL SYNDROME TO GASTROINTESTINAL CLINICAL TRIALS, E7 COUNTRIES (%), 2017*

Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2017" provides an overview of Irritable Bowel Syndrome clinical trials scenario. This report provides top line data relating to...

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • GlaxoSmithKline plc
  • Official Title

The prominent features of this report are - ##.

  • Clinical Trial
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trial profile. 920 Trial Title
  • Clinical Trial profile. 842 Trial Title

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Clinical Trials by G7 Countries: Proportion of Acid Indigestion / Heartburn/ Pyrosis to Gastrointestinal Clinical Trials
  • Clinical Trials by E7 Countries: Proportion of Acid Indigestion / Heartburn/ Pyrosis to Gastrointestinal Clinical Trials

Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2017" provides an overview of Acid Indigestion / Heartburn/ Pyrosis clinical trials scenario. This report provides top...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • World
  • Product Initiative
  • ASTRAZENECA ENTERS INTO CO-DEVELOPMENT AGREEMENT WITH IRONWOOD PHARMA FOR LINACLOTIDE
  • PARTNERSHIPS

Linaclotide Delayed Release-## (DR##).

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Company Financials
  • Ironwood Pharmaceuticals, Inc.
  • PROPORTION OF DIARRHEA TO GASTROINTESTINAL CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • PROPORTION OF DIARRHEA TO GASTROINTESTINAL CLINICAL TRIALS, E7 COUNTRIES (%), 2017*

Diarrhea Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Diarrhea Global Clinical Trials Review, H2, 2017" provides an overview of Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Diarrhea. Report includes an overview of trial...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Product Initiative
  • MICROCAM NAVI - UPPER GASTROINTESTINAL DISORDERS - PRODUCT STATUS
  • MICROCAM NAVI - UPPER GASTROINTESTINAL DISORDERS - PRODUCT DESCRIPTION

Capsule Endoscopes - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Capsule Endoscopes - Medical Devices Pipeline Assessment, 2017" provides an overview of Capsule Endoscopes currently in pipeline stage. The report provides comprehensive information on the pipeline...

  • Clinical Trial
  • Endoscopic Device
  • Gastrointestinal Drug
  • Company
  • GlobalData's company
  • Target
  • Clinical Trial profile. 21 Trial Title

Acidity Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acidity Global Clinical Trials Review, H1, 2017" provides an overview of Acidity clinical trials scenario. This report provides top line data relating to the clinical trials on Acidity. Report includes an overview of trial...

  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative
  • Bayer AG
  • PROPORTION OF CONSTIPATION TO GASTROINTESTINAL CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF CONSTIPATION TO GASTROINTESTINAL CLINICAL TRIALS

Constipation Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Constipation Global Clinical Trials Review, H1, 2017" provides an overview of Constipation clinical trials scenario. This report provides top line data relating to the clinical trials on Constipation. Report includes an...

  • Drug Discovery And Development
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trials by E7 Countries: Proportion of Acid Indigestion / Heartburn/ Pyrosis to Gastrointestinal Clinical Trials
  • Clinical Trials by G7 Countries: Proportion of Acid Indigestion / Heartburn/ Pyrosis to Gastrointestinal Clinical Trials

Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H2, 2016" provides an overview of Acid Indigestion / Heartburn/ Pyrosis clinical trials scenario. This report provides top line...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • World
  • Product Initiative
  • Clinical Trial profile. 121 Trial Title
  • Clinical Trial profile. 46 Trial Title

Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, E## Countries (%), 2016* Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, E## Countries (%), 2016* Proportion of Zollinger-Ellison Syndrome (Gastrinoma

  • Gastrointestinal Drug
  • Hospital
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trial profile. 23 Trial Title
  • Target

Proportion of Nonerosive Reflux Disease (NERD) to Gastrointestinal Clinical Trials, E## Countries (%), 2016* Proportion of Nonerosive Reflux Disease (NERD) to Gastrointestinal Clinical Trials, E## Countries (%), 2016* Proportion of Nonerosive Reflux Disease (NERD) to

  • Gastrointestinal Drug
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • NARONAPRIDE - DRUG PROFILE
  • YH-12852 - DRUG PROFILE

The molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are ##, ##, ## and ## respectively.

  • Gastrointestinal Drug
  • Japan
  • World
  • Product Initiative
  • RaQualia Pharma Inc.
  • NARONAPRIDE - DRUG PROFILE

The molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are ##, ##, ## and ## respectively.

  • Gastrointestinal Drug
  • Japan
  • World
  • Product Initiative
  • RaQualia Pharma Inc.
  • Clinical Trial profile. 19 Trial Title
  • Clinical Trial profile. 13 Trial Title

The prominent features of this report are - ##.

  • Gastrointestinal Drug
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • Proportion of Constipation to Gastrointestinal Clinical Trials, G7 Countries (%), 2016*
  • Clinical Trials by G7 Countries: Proportion of Constipation to Gastrointestinal Clinical Trials

Constipation Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Constipation Global Clinical Trials Review, H2, 2016" provides an overview of Constipation clinical trials scenario. This report provides top line data relating to the clinical trials on Constipation. Report includes an overview...

  • Clinical Trial
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Product Initiative

It acts by targeting cannabinoid receptor ## and cannabinoid receptor ##.

  • Gastrointestinal Drug
  • Opioid
  • Turkey
  • United States
  • World
  • Clinical Trial profile. 127 Trial Title
  • Clinical Trial profile. 32 Trial Title

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Clinical Trial profile. 64 Trial Title
  • Clinical Trial profile. 168 Trial Title

Ulcers Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Ulcers Global Clinical Trials Review, H2, 2016" provides an overview of Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Ulcers. Report includes an overview of trial numbers...

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Clinical Trial profile. 43 Trial Title
  • Clinical Trial profile. 37 Trial Title

The prominent features of this report are - ##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative
  • Legal Advisor
  • Deal Rationale

The event will feature one-on-one meetings with specialty pharmaceutical companies for institutional clients of Oppenheimer & Co.

  • Gastrointestinal Drug
  • Healthcare
  • Pharmaceutical
  • United States
  • Evoke Pharma, Inc.
  • Opioid-Induced Constipation (OIC) - Pipeline by Theravance Biopharma Inc, H2 2017
  • GI INFLAMMATION VIA A CYCLIC GMP MEDIATED MECHANISM TO DOWNREGULATE IKK AND NF-KAPPAB."

These medicines affect the gastrointestinal tract in a variety of ways.

  • Gastrointestinal Drug
  • Opioid
  • United States
  • World
  • Product Initiative
  • CHIRONWELLS GMBH

It acts by targeting cannabinoid receptor ## and cannabinoid receptor ##.

  • Gastrointestinal Drug
  • Turkey
  • United States
  • World
  • Product Initiative
  • SYNERGY PHARMA ENTERS INTO AGREEMENT WITH IRONWOOD PHARMA FOR PLECANATIDE
  • Deal Rationale

The notes are unsecured, senior obligations of the company and will be payable semiannually in arrears on May ## and November ## of each year, beginning on May ##, 2015.

  • Gastrointestinal Drug
  • Pharmaceutical
  • Therapy
  • United States
  • Synergy Pharmaceuticals, Inc.
  • LICENSING AGREEMENTS
  • Deal Type

Patients were randomized one to one to receive either ## mg of tenapanor (n=##) or placebo (n=##) twice-daily.

  • Gastrointestinal Drug
  • Therapy
  • United States
  • Company Operations
  • Ardelyx, Inc.
  • Clinical Trial profile. 125 Trial Title
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • Jul 25, 2016: Biomerica Forms Strategic Advisory Board
  • Aug 30, 2016: Biomerica Announces Year End Results

He is an accomplished expert in afflictions of the gastrointestinal tract and IBS.

  • Gastrointestinal Drug
  • United States
  • World
  • Company Financials
  • Biomerica, Inc.
  • Constipation - Drug Profiles
  • DA-6886 - DRUG PROFILE

Study subjects will be randomized in a ##:##:## ratio, receiving either ## mg of SYN-##, ## mg of SYN-##, or placebo.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Proportion of Traveler's Diarrhea to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Proportion of Traveler's Diarrhea to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*

Traveler's Diarrhea Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Traveler's Diarrhea Global Clinical Trials Review, H2, 2015" provides an overview of Traveler's Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Traveler's Diarrhea....

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Healthcare
  • World
  • Product Initiative
  • JAN 12, 2017: REDHILL BIOPHARMA PROVIDES MILESTONE UPDATE ON RHB-105
  • JAN 12, 2017: REDHILL BIOPHARMA PROVIDES MILESTONE UPDATE ON RHB-105

IBS is one of the most common gastrointestinal disorders.

  • Biopharmaceutical
  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • RedHill Biopharma Ltd.